GLP-1 weight loss drugs may be sparing muscle more than anyone expected
A review of 36 studies on GLP-1 medications suggests most of the weight lost comes from fat, not muscle, offering some reassurance to the millions now using these drugs. GLP-1 medications have moved from niche diabetes treatment to one of the most prescribed drug categories in the country in a remarkably […]
Ozempic breath is a real problem: here’s what causes it
GLP-1 receptor agonist medications like Ozempic and Wegovy have become some of the most talked about drugs in recent years, largely praised for their effectiveness in managing type 2 diabetes and supporting weight loss. But alongside the well known gastrointestinal complaints nausea, bloating, and constipation a lesser discussed side effect has been making its way […]
Are GLP-1 drugs secretly straining your marriage
The conversation around GLP-1 medications has long centered on nausea, appetite suppression and the dramatic weight loss results that have made drugs like Ozempic, Wegovy and Mounjaro household names. But a growing number of users and medical professionals are drawing attention to a side effect that has nothing to do with the body and everything […]
Ways GLP-1 drugs affect your sex life
Medications known as GLP-1 receptor agonists have quickly become household names, widely used for managing Type 2 diabetes and supporting weight loss. Drugs like Ozempic, Wegovy, Mounjaro, and Zepbound are often discussed in terms of shrinking waistlines. But researchers are beginning to ask a more personal question: Could these medications also be reshaping people’s sex […]
Mounjaro vs. Wegovy: What happens when you stop them
An estimated 1.6 million people in the United Kingdom are currently taking weight-loss drugs, and the numbers continue to grow. While some access these treatments through the National Health Service, the majority purchase them privately. The two most widely used options are Mounjaro and Wegovy injectable medications that have changed the conversation around obesity treatment. […]
Why Ozempic triggers hair loss and 3 ways to fight back
As GLP-1 medications like Ozempic, Wegovy, Mounjaro, and Zepbound become increasingly common, so do questions about their side effects and one of the most searched is whether these drugs cause hair loss. For women already navigating hormonal hair changes in their 40s and 50s, the concern carries extra weight. The answer, according to dermatologists and […]
The alarming truth about stopping GLP-1 drugs and heart health
For patients with type 2 diabetes who take GLP-1 medications, the cardiovascular benefits do not come quickly but they can disappear fast. That is the central and sobering finding of a newly published study in the British Medical Journal, which followed more than 333,000 adults with type 2 diabetes over three years to examine what […]
Wegovy is rewriting the rules of cardiovascular care with a groundbreaking new approval
Wegovy, the injectable medication best known for its role in weight management, has just been cleared for a purpose that extends well beyond the scale. Britain’s national health technology authority has recommended Wegovy for use in reducing the risk of major cardiovascular events, including heart attacks, strokes, and cardiovascular death, in adults who are living […]
Key changes GLP-1 users are making at the grocery store
In recent years, medications designed to support weight management have become a growing part of everyday health conversations. Drugs known as GLP-1 receptor agonists, including Ozempic and Wegovy, are increasingly being used to help regulate appetite and blood sugar levels. Now, new research suggests these medications may also be quietly reshaping how people shop for […]
Is retatrutide more effective than Ozempic for weight loss
Retatrutide still experimental and not yet approved by the U.S. Food and Drug Administration, the medication is already reshaping the way researchers think about weight loss medicine. Here is what experts currently know about it. Now, a newer drug is quietly generating some of the most significant buzz in clinical research. By now, most people […]